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PAD patients who undergo more invasive revascular-
ization procedures are more likely to decrease or quit
smoking
Sareh Rajaee, Edward J. Marcaccio, Wilfred I. Carney, Tze
Tec Chong, Manuel Garcia-Toca, Jeffrey M. Slaiby. De-
partment of Vascular Surgery, Warren Alpert Medical
School at Brown University, Providence, RI
Objectives: To determine if PAD patients who un-
dergo surgical revascularization procedures are more likely
to change their smoking habits than those who undergo
percutaneous revascularization. This study assesses changes
in smoking habits following intervention via patient-an-
swered surveys and retrospective chart review.
Methods: Study participants included patients seen
between 2005 and 2010 and assigned ICD.9 code diagno-
ses of PVD, claudication, or PAD. 500 participants were
identified belonging to 1 of 3 intervention groups (medi-
cal, percutaneous, or surgical), of which 142 submitted
surveys. Here we present a preliminary analysis of 55 pa-
tients who were active smokers at the time of intervention.
An interrater reliability analysis using the Kappa statistic
was used to compare survey-reported and medical record
documented smoking habit change. A Fisher’s exact test
was used to compare smoking habit change among percu-
taneous and surgically treated groups. A logistic regression
analysis was performed to determine if surgical revascular-
ization independently predicts a decrease in smoking while
controlling for potential confounders. Historical elements
were extracted from themedical record and included: ABIs,
history of CAD, diabetes, COPD, stroke, alcohol use, and
marriage status.
Results: 36% (n20) of the patients underwent surgi-
cal revascularization and 42% (n23) underwent percuta-
neous revascularization. The Kappa value was 0.54 (p
0.001). 94% of the patients believed that smoking was a
significant contributor to their PAD. The Fisher’s exact test
revealed a higher proportion of patients who quit or cut
down on smoking after surgical intervention compared to
percutaneous intervention (95% vs 61%, p0.011). This
association remained after controlling for confounders (OR
0.02, 95% CI 0.001-0.47, p0.03).
Conclusions: Patients with PAD who undergo a more
invasive revascularization, such as surgical bypass, are more
likely to quit or cut down on smoking than those who
undergo percutaneous procedures.
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Duplex-Guided Office-Based Arterio-venous Fistula
Thrombectomy: A Novel Technique
Anil Hingorani, Division of Vascular Services, Maimonides
Medical Center, Brooklyn, NY
Objectives: Autologous arterial-venous accesses
(AVA) have been shown to be superior to the ones created
with synthetic material. Accordingly, several strategies have
been developed to extend the salvage rates for failing or
failed AVAs. We analyzed our aggressive approach to sal-
vaging acutely occluded AVAs in an office setting using
duplex scanning.
Methods: Over 12 months, 14 patients with acute
thrombosis of their AVA underwent 18 procedures for
salvage at our office. there were 10 (71%) radial-cephalic
and 4 (29%) brachial-cephalic fistulas. Presence of throm-
bus, as confirmed by preoperative duplex, served as the
indication for 16 (89%) of the cases. Acute thrombosis
during routine angioplasty was the indication for the re-
maining 2(11%) of the cases. Of the 14 patients, thrombus
was located at the perianastomotic AVF in 6 (43%), prx-
mid AVF in 6 (43%), mid AVF in 1 (7%), dist AVF in
1 (7%). Treatment included balloon dilation and masera-
tion (group A), 10(56%) or pharmaco-mechanical throm-
bectomy (group B), 8,(44%). Of the 18 procedures,
13 (72%) were successful.
Results: All patients were treated under duplex-guid-
ance alone. Full restoration of fistula flow was established in
14 cases (78%). Early re-thrombosis (1 mo patency)
occurred in 3 cases (17%), these patients received new
fistulas. From group A, 6 (60%) were successful. From
group B, 7 (88%) were successful. The 1 case that was
unsuccessful was the patient with a history of PCV. Of the
14 patients, 8 (57%) are currently on hemodialysis via fis-
tula. 3 patients (21%) had newly placed fistulas after failed
interventions. 2 patients (14%) are not on dialysis yet. 1
patient (7%) with PCV disorder is on dialysis via tesio.
Conclusions: This small series demonstrates that ultra-
sound alone can be not only be used as an important
diagnostic tool preoperatively but also to guide treatment
of acutely occluded arteriovenous fistulae.
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Safety and Efficiacy of Rapid Autologous Bone Marrow
Aspirate Concentrate for the Treatment of Critical
Limb Ischemia in Buerger’s Disease
Radhakrishnan Raju, Sivaraman G. Mani, Vijayaraghavan
Kuppu Sampath. Vascular Surgery, Sri Ramachandra Uni-
versity, Chennai, India
Objectives: Patients diagnosed with critical limb isch-
emia, have high risk of limb loss and a shortened life
expectancy. The end stage of this deteriorating disease
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